Jadersten, M., Pellagatti, A., Forsblom, A., Emanuelsson, E., Merup, M., Samuelsson, J., . . . Hellstorm-Lindberg, E. (2005). Lenalidomide selectively inhibits in vitro growth of the malignant clone in myelodysplastic syndrome (MDS) patients with 5q deletion.
Citación estilo ChicagoJadersten, M., A. Pellagatti, A. Forsblom, E. Emanuelsson, M. Merup, J. Samuelsson, J. Wainscoat, J. Boultwood, and E. Hellstorm-Lindberg. Lenalidomide Selectively Inhibits in Vitro Growth of the Malignant Clone in Myelodysplastic Syndrome (MDS) Patients with 5q Deletion. 2005.
Cita MLAJadersten, M., et al. Lenalidomide Selectively Inhibits in Vitro Growth of the Malignant Clone in Myelodysplastic Syndrome (MDS) Patients with 5q Deletion. 2005.
Warning: These citations may not always be 100% accurate.